According to the protein density visualized using silver, Apo-A1 showed very low expression in urine samples of healthy individuals and patients with bladder benign damages, while significant increase in urine samples of patients with bladder cancer, particularly in those diagnosed as aggressive BTCC. Here, APOA1 is linked to urinary bladder cancer.